SM
ONSIZ

Sabby Management’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Sabby Management’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-199,193
Closed -$4K – 229
2017
Q4 		$4K Sell
199,193
-60,825
-23% -$3K ﹤0.01% 158
2017
Q3 		$13K Sell
260,018
-240,606
-48% -$15.8K ﹤0.01% 162
2017
Q2 		$428K Sell
500,624
-429,648
-46% -$78.2K 0.03% 151
2017
Q1 		$456K Hold
930,272
– – 0.02% 183
2016
Q4 		$726K Buy
930,272
+3,621
+0.4% +$2.79K 0.04% 168
2016
Q3 		$1.33M Buy
926,651
+489,728
+112% +$357K 0.05% 161
2016
Q2 		$196K Buy
+436,923
New +$230K 0.01% 249

Other funds holding ONSIZ

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sabby Management's ONSIZ Position: Q1 2018 in Review

Sabby Management sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q1 2018, closing a stake of 199,193 shares — an estimated $4K sold.

Sabby Management first reported a position in ONSIZ in Q2 2016 and held it in 7 quarters. The position peaked at $1.33M in Q3 2016. 9 funds tracked by Wall St. Rank hold ONSIZ as of Q1 2018.

  • Sabby Management reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q1 2018 after selling out during the quarter.
  • Sabby Management sold 199,193 Oncobiologics, Inc. Series B Warrant shares in Q1 2018, an estimated $4K.
  • Sabby Management first reported a position in Oncobiologics, Inc. Series B Warrant in Q2 2016 and held it in 7 quarters.
  • Sabby Management's Oncobiologics, Inc. Series B Warrant position peaked at $1.33M in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q1 2018.

Based on Sabby Management's 13F filing for Q1 2018, filed 15 May 2018.